QuantiPath Introduces Expanded À La Carte Multiplex Options
PR Newswire —
DENVER, Jan. 15, 2026 /PRNewswire/ -- QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a significant expansion of its molecular diagnostics portfolio with enhanced à la carte multiplex Salmonella primer and probe options...